These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7832436

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Attenuation and delay of diabetic cataracts by antioxidants: effectiveness of pyruvate after onset of cataract.
    Varma SD, Hegde KR, Kovtun S.
    Ophthalmologica; 2005; 219(5):309-15. PubMed ID: 16123559
    [Abstract] [Full Text] [Related]

  • 25. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.
    Suresha BS, Sattur AP, Srinivasan K.
    Can J Physiol Pharmacol; 2012 Apr; 90(4):387-94. PubMed ID: 22423974
    [Abstract] [Full Text] [Related]

  • 26. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.
    Du L, Hao M, Li C, Wu W, Wang W, Ma Z, Yang T, Zhang N, Isaac AT, Zhu X, Sun Y, Lu Q, Yin X.
    Mol Cell Endocrinol; 2017 Sep 05; 452():44-56. PubMed ID: 28501572
    [Abstract] [Full Text] [Related]

  • 27. In vivo assessment of an animal model of diabetic cataract: medical intervention studies.
    Joon TL, Foo K, Panagiotopoulos S, Jerums G, Taylor HR.
    Dev Ophthalmol; 1994 Sep 05; 26():57-62. PubMed ID: 7895883
    [No Abstract] [Full Text] [Related]

  • 28. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
    Suresha BS, Srinivasan K.
    Curr Eye Res; 2013 Oct 05; 38(10):1064-71. PubMed ID: 23767695
    [Abstract] [Full Text] [Related]

  • 29. α-Lipoic acid normalizes nociceptive neuronal activity at the spinal cord of diabetic rats.
    Morgado C, Pereira-Terra P, Tavares I.
    Diabetes Obes Metab; 2011 Aug 05; 13(8):736-41. PubMed ID: 21435143
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The pyrimido-pyrimidine derivatives, dipyridamole and RA-642, reduce opacification of crystalline lens in diabetic rats.
    de la Cruz JP, Moreno A, Mérida F, García-Campos J, Sánchez de la Cuesta F.
    Pharmacol Toxicol; 1994 Nov 05; 75(5):250-4. PubMed ID: 7870694
    [Abstract] [Full Text] [Related]

  • 33. Effect of nifedipine on severe experimental cataract in diabetic rats.
    Kametaka S, Kasahara T, Ueo M, Takenaka M, Saito M, Sakamoto K, Nakahara T, Ishii K.
    J Pharmacol Sci; 2008 Apr 05; 106(4):651-8. PubMed ID: 18431041
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ursodeoxycholic acid suppresses the formation of fructose/streptozotocin-induced diabetic cataract in rats.
    Abdel-Ghaffar A, Ghanem HM, Ahmed EK, Hassanin OA, Mohamed RG.
    Fundam Clin Pharmacol; 2018 Dec 05; 32(6):627-640. PubMed ID: 29863796
    [Abstract] [Full Text] [Related]

  • 37. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA.
    Diabetes; 2001 Aug 05; 50(8):1927-37. PubMed ID: 11473057
    [Abstract] [Full Text] [Related]

  • 38. Decreased O-GlcNAcylation of the key proteins in kinase and redox signalling pathways is a novel mechanism of the beneficial effect of α-lipoic acid in diabetic liver.
    Dinić S, Arambašić J, Mihailović M, Uskoković A, Grdović N, Marković J, Karadžić B, Poznanović G, Vidaković M.
    Br J Nutr; 2013 Aug 28; 110(3):401-12. PubMed ID: 23312093
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Natural therapies for ocular disorders, part two: cataracts and glaucoma.
    Head KA.
    Altern Med Rev; 2001 Apr 28; 6(2):141-66. PubMed ID: 11302779
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.